New York, NYCIK 18250344 filings on record
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeLargest positions by weight
12 positions · Q4 2025
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Vanguard Intl Equity Index F | 2.99M | $219.95M | 59.5% | +411.9K | Added |
| 2 | Vanguard Index Fds | 520.0K | $99.31M | 26.9% | +520.0K | New |
| 3 | Ishares Tr | 369.6K | $19.98M | 5.4% | 0 | Held |
| 4 | Foghorn Therapeutics Inc |
| 1.57M |
| $8.50M |
| 2.3% |
| 0 |
| Held |
| 5 | Oric Pharmaceuticals Inc | 989.4K | $8.09M | 2.2% | 0 | Held |
| 6 | Pmv Pharmaceuticals Inc | 2.63M | $3.28M | 0.9% | 0 | Held |
| 7 | Spdr S&P 500 ETF Tr | 4.1K | $2.80M | 0.8% | 0 | Held |
| 8 | Rapt Therapeutics Inc | 82.2K | $2.79M | 0.8% | 0 | Held |
| 9 | Alector Inc | 1.31M | $2.04M | 0.6% | 0 | Held |
| 10 | Surrozen Inc | 87.7K | $1.98M | 0.5% | 0 | Held |
See this fund's complete portfolio, full position changes, and activity history.
Unlock full portfolio